RGCON 2020 focussed on Hemato-oncology update

Image
ANI
Last Updated : Feb 06 2020 | 6:10 PM IST

RGCON 2020, the 19th Annual International Conference of Rajiv Gandhi Cancer Institute and Research Centre to be held in New Delhi from February 7 to 9, 2020, is focused on an all-important aspect of Hemato-oncology update.

Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, Sickle Cell Disease, Thalassemia as well as cancers of other organs.

"Renowned national and international experts in the field of Haematology, Hemato-oncology and Stem Cell Transplant have committed their participation to share their views and deliver lectures on the current practices," said Dr Dinesh Bhurani, Director, Department of Hemato-Oncology and Bone Marrow Transplant, RGCIRC and Organising Secretary - RGCON 2020.

"As a distinctive feature, RGCON 2020 will cover latest updates from American Society of Haematology (ASH) and American Society of Clinical Oncology (ASCO) and various other events," added Dr Bhurani.

"Over the years, the aim of RGCON has been to bring eminent international and national faculty at one platform to share new advances in oncology and haematology leading to good interaction between faculty and delegates. We are fortunate to have distinguished international and national faculty for RGCON 2020 too," said Dr Sudhir Kumar Rawal, Medical Director and Chief of GenitoUro - Oncology Services RGCIRC.

Another unique feature of RGCON 2020 is a get together of Myeloma patients. The first Myeloma patient who got CarT cell treatment from China will also be present and share her experience.

"Over the years, Hemato-Oncology has witnessed some path-breaking advancements. Blood cancers are treated with chemotherapy while some require bone marrow transplant. Now, Targeted Therapy and Immunotherapy are fast taking the place of chemotherapy in the treatment of blood cancers. Under immunotherapy, the body's own T cells are modified to kill cancer cells," added Dr Bhurani.

Blood cancers account for around 20 per cent of the total cancers in India. Different blood cancers occur at different age groups. Leukaemia occurs in children while Lymphoma and Myeloma generally occur in old age.

Speaking about causes of blood cancers, Dr Bhurani stated, blood cancers generally don't have any direct causal relationship. Blood cancers are due to genetic changes in cells and generally not linked to any preventive causes.

The symptoms of blood cancers include fever and bleeding from any part - nose, mouth etc in case of leukaemia and lumps in the neck in case of Lymphoma.

Rajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia's premier exclusive cancer centres that offer the unique advantage of cutting edge technology, put to use by renowned super-specialists.

Ever since its inception, RGCIRC has taken care of over two lakh patients. RGCIRC has earned repute across India as well as internationally for its services in the field of oncology, haematology and bone marrow transplantation.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 06 2020 | 5:58 PM IST

Next Story